A microbiology service for communicable-disease epidemiology

Regulation of the cardiac sodium pump.

Cellular and molecular life sciences : CMLS·2012

Re-evaluation of a randomized controlled trial of antibiotics for minor respiratory illness in general practice.

Family practice·2001

A study of interruption rates for practice nurses and GPs.

Nursing standard (Royal College of Nursing (Great Britain) : 1987)·1996

Grandparent/caretaker education session.

The Diabetes educator·1991

Rezpegaldesleukin treatment of moderate-to-severe atopic dermatitis (REZOLVE-AD): final results from the 16-week induction period of an international, double-blind, placebo-controlled, randomised phase 2b study.

Lancet (London, England)·2026

Robotic-arm-assisted versus conventional total knee replacement (RACER-Knee): a pragmatic, multicentre, participant-masked and assessor-masked, superiority, randomised controlled trial.

Lancet (London, England)·2026

Risk of transmission of amyloid β pathology via transfused blood products.

Lancet (London, England)·2026

Liver resection after atezolizumab and bevacizumab versus maintenance therapy for locally advanced hepatocellular carcinoma (TALENTOP): a multicentre, open-label, randomised, phase 3 trial.

Lancet (London, England)·2026

Metagenomic Characterization of Nitrite-Negative Urinary Tract Infections and Identification of an optrA-fexA Co-Localization in a Primary Healthcare Setting in China.

Infection and drug resistance·2026

Impact of medium composition on cefiderocol susceptibility testing: comparison of CLSI/EUCAST-compliant and commercial broth microdilution methods.

JAC-antimicrobial resistance·2026

Case Report: Methemoglobinemia associated with compound aminopyrine-phenacetin tablets supported by toxicological evidence.

Frontiers in pharmacology·2026

Genomic characterization of drug-resistant Mycobacterium tuberculosis complex in western Kenya reveals predominance of isoniazid resistance and discordance with routine susceptibility testing.

Frontiers in tuberculosis·2026

Innovative laboratory methods for improved tuberculosis diagnosis and drug-susceptibility testing.

Frontiers in tuberculosis·2026

Novel diagnostic test for the detection of Mycobacterium tuberculosis and its resistance to rifampicin, isoniazid, and fluoroquinolones directly in sputum samples.

Frontiers in tuberculosis·2026

Related Experiment Videos

A microbiology service for communicable-disease epidemiology

Related Concept Videos

Regulation of the cardiac sodium pump.

Re-evaluation of a randomized controlled trial of antibiotics for minor respiratory illness in general practice.

A study of interruption rates for practice nurses and GPs.

Grandparent/caretaker education session.

Rezpegaldesleukin treatment of moderate-to-severe atopic dermatitis (REZOLVE-AD): final results from the 16-week induction period of an international, double-blind, placebo-controlled, randomised phase 2b study.

Robotic-arm-assisted versus conventional total knee replacement (RACER-Knee): a pragmatic, multicentre, participant-masked and assessor-masked, superiority, randomised controlled trial.

Risk of transmission of amyloid β pathology via transfused blood products.

Liver resection after atezolizumab and bevacizumab versus maintenance therapy for locally advanced hepatocellular carcinoma (TALENTOP): a multicentre, open-label, randomised, phase 3 trial.

Metagenomic Characterization of Nitrite-Negative Urinary Tract Infections and Identification of an optrA-fexA Co-Localization in a Primary Healthcare Setting in China.

Impact of medium composition on cefiderocol susceptibility testing: comparison of CLSI/EUCAST-compliant and commercial broth microdilution methods.

Case Report: Methemoglobinemia associated with compound aminopyrine-phenacetin tablets supported by toxicological evidence.

Genomic characterization of drug-resistant Mycobacterium tuberculosis complex in western Kenya reveals predominance of isoniazid resistance and discordance with routine susceptibility testing.

Innovative laboratory methods for improved tuberculosis diagnosis and drug-susceptibility testing.

Novel diagnostic test for the detection of Mycobacterium tuberculosis and its resistance to rifampicin, isoniazid, and fluoroquinolones directly in sputum samples.

Related Experiment Videos

A microbiology service for communicable-disease epidemiology

Related Concept Videos

Related Articles